GlassScriptPhysician profile
Majid Torabi
NPI 1598721474
$4,391.93
in general payments reported to CMS, 2019-2025
29 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2020: $254 · 2021: $348 · 2022: $437 · 2023: $732 · 2024: $712 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,590.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $957.54 | 2022-2025 | |
| Glaxosmithkline, LLC. | $572.21 | 2021-2025 | Nucala |
| Csl Behring | $424.23 | 2019-2025 | Andembry, Haegarda |
| Takeda Pharmaceuticals U.S.A., INC. | $300.65 | 2021-2024 | Takhzyro |
| Astrazeneca Pharmaceuticals LP | $246.16 | 2019-2025 | Tezspire |
| Genentech USA, INC. | $203.20 | 2019-2025 | Xolair |
| Integra Lifesciences Corporation | $197.13 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Pharming Healthcare, INC. | $168.49 | 2019-2025 | Ruconest |
| Optinose US, INC. | $157.23 | 2019-2025 | |
| Becton, Dickinson and Company | $155.41 | 2019 | |
| Hologic Sales and Service, LLC | $153.37 | 2023-2024 | Coolseal Generator |
| Acclarent, INC | $133.48 | 2020 | |
| Biocryst US Sales Co., LLC | $130.97 | 2022-2024 | Orladeyo |
| Shire North American Group INC | $115.61 | 2019 | |
| Ionis Pharmaceuticals, INC. | $61.26 | 2025 | Dawnzera |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $55.82 | 2021-2025 | Tula |
| Aerin Medical INC. | $51.32 | 2020 | |
| Stryker Corporation | $42.21 | 2021 | |
| Emd Serono, INC. | $36.57 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $34.35 | 2023 | Dupixent |
| Merck Sharp & Dohme LLC | $31.79 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $28.86 | 2024 | Voquezna |
| Itamar Medical INC | $22.93 | 2024 | Watchpatone |
| Amgen INC. | $22.55 | 2025 | |
| Phadia US INC. | $21.90 | 2025 | Immunocap |
| Davol INC. | $19.36 | 2020 | |
| Neurent Medical Limited | $17.15 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Biohaven Pharmaceuticals, INC. | $16.94 | 2021 | |
| Kaleo, INC. | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Majid Torabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.